logo
Share SHARE
FONT-SIZE Plus   Neg

GenVec Names Cynthia Collins President, CEO - Quick Facts

GenVec, Inc. (GNVC) said it appointed Cynthia Collins as president and chief executive officer, or CEO, effective May 23, 2012. Besides, Collins is expected to be appointed to the Board of Directors of GenVec.

Effective upon Collins' appointment, Paul Fischer will step down as GenVec's president and CEO and as a member of the Board.

Collins formerly served as Group vice president, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011. Before joining Beckman Coulter, she served as CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs. Before that, she served as president of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Spanish fashion retailer Industria de Diseño Textil SA or Inditex reported Wednesday higher profit in its first half with strong like-for-like sales growth growth. EBITDA, a key earnings metric, improved 9 percent, while gross margin declined. Inditex shares were losing around 3 percent in the morning trading. Microsoft (MSFT) announced Wednesday that Xbox One X standard edition is now available to pre-order worldwide. The company said more than 130 games have now been enhanced for the system. Beginning today, the console, said to be the most powerful ever, can be booked from local retailers around the... German industrial conglomerate thyssenKrupp AG announced Wednesday that it has signed a memorandum of understanding or MoU with Tata Steel Ltd. about the combination of their European steel activities in a 50/50 joint venture. The companies expect up to 4000 job cuts in the joint venture.
comments powered by Disqus
Follow RTT